2Maekawa H, Yoshikawa Y, Toda G, et al. Evaluation of plasma tissue plasminogen activator(T-PA) levels in patients with liver disease. Nippon Shokakibyo Gakkai Zasshi, 1990, 87(1): 62-68
3Kohda K, Ha-Kawa SK, Yamano R, et al. Change in lobar uptake of 99mTc-galactosyl serum albumin after transarterial embolization therapy. Nippon Igaku Hoshasen Gakkai Zasshi, 1994, 54(14): 1427-1429
4Castaneda F, Kinne RK. Effects of doxorubicin, mitomycin C, and ethanol on Hep-G2 ceils in vitro. J Cancer Res Clin Oncol, 1999, 125(1): 1-8
5Tsukidate K, Yamamoto K, Snyder JW, et al. Microtubule antagonists activate programmed cell death(apoptosis) in cultured rat hepatocytes. Am J Pathol, 1993, 143(3): 918-925
6Kobayashi S, Nakanuma Y, Matsui O. Histopathology of portal tracts in livers after transcatheter arterial chemo - embolization therapy for hepatocellular carcinoma. J Gastroenterol Hepatol, 1994, 9(1): 45-54
7Taourel P, Dauzat M, Lafortune M, et al. Hemodynamic changes after transcatheter arterial embolization of hepatocellular carcinomas. Radiology, 1994, 191(1): 189-192
8Hashimoto L, Ouchi K, Suzuki M, et al. Energy metabolism changes and oxidative attack after hepatic arterial embolization and chemoembolization in thioacetamide- induced cirrhotic livers. Res Exp Med (Berl), 1991, 191(2): 91-98
9Suzuki H, Mori M, Kawaguchi C, et al. Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma. J Oncol, 1999, 14(6): 1087-1090
10Iwamiya T, Sawada S, Fujiwara Y, et al. Usefulness of dopamine administration after transcatheter hepatic arterial embolization based upon portal hemodynamics. Nippon Igaku Hoshasen Gakkai Zasshi, 1992, 52(1): 104-106
